6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Prenatal Exposure to Substances and Developmental Outcomes
Prenatal substance exposure can have profound effects on fetal development, leading to physical, cognitive, and behavioral challenges. Substances like alcohol, opioids, and cocaine disrupt normal brain development, increasing risks of neonatal abstinence syndrome (NAS), developmental delays, and learning disabilities. Long-term effects may include attention deficits, emotional dysregulation, and social difficulties. Early intervention programs, such as occupational therapy and developmental assessments, are essential for mitigating these outcomes. Educating expectant mothers about the risks and providing access to addiction treatment during pregnancy can significantly improve developmental outcomes for affected children. Comprehensive care ensures a healthier start for both mother and child.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States